Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 20 (2) , 45-59
- https://doi.org/10.1023/a:1008605600414
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Complications of an implantable venous access device (Port-a-Cath®) during intermittent continuous infusion of chemotherapyEuropean Journal Of Cancer, 1996
- Different dose regimens of 5-fluorouracil and interferon-α in patients with metastatic colorectal carcinomaEuropean Journal Of Cancer, 1995
- Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: Relationship between plasma concentrations and clinical parametersEuropean Journal Of Cancer, 1995
- Intermittent continuous intravenous infusion of 5-fluoruoracil; a useful approach in disseminated colorectal cancer?European Journal Of Cancer, 1993
- Infusion of floxuridine plus etoposide plus cisplatin in human malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid-atlantic oncology program studyCancer, 1991
- Determination of the Therapeutic Index of Floxuridine by Its Circadian Infusion PatternJNCI Journal of the National Cancer Institute, 1990
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- The effect of time of administration of 5-fluorouracil on leucopenia in the ratEuropean Journal of Cancer and Clinical Oncology, 1984
- Effect of Biological Time on the Determination of the LD50 of 5-Fluorouracil in MicePharmacology, 1984